Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ISRCTN14700344) titled 'Erythropoietin treatment for patients with sepsis and severe lung injury' on April 15.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Open (masking not used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: Sir Run Run Hospital of Nanjing Medical University
Condition:
Sepsis-associated acute respiratory distress syndrome in adult intensive care unit patients requiring ventilatory support and blood purification treatment.
Respiratory
Intervention:
Eligible adult patients with sepsis-associated acute respiratory distress syndrome will be ran...